期刊文献+

关于药物洗脱支架再狭窄研究的进展

Research progress for in-stent restenosis of drug-eluting stent
下载PDF
导出
摘要 支架内再狭窄是介入治疗技术中面临的重要医学难题,药物洗脱支架明显降低支架内再狭窄率,然而在抑制血管平滑肌细胞过度增殖的同时,也抑制了支架处内皮功能和生长,其内皮化延迟可导致晚期再狭窄及延迟血栓的形成。本文就药物洗脱支架再狭窄现状、影响因素、发生机制和各种治疗方法的研究进展做一综述。 In-stent restenosis is an important medical problem in interventional therapy .Drug-eluting stent (DES) can significantly reduce in-stent restenosis rate .However ,it also inhibits function and growth of endothelium in stent site while inhibiting over-proliferation of vascular smooth muscle cells .Delayed endothelialization can lead to late restenosis and delayed thrombosis .The present article made an overview on research progress of DES restenosis current condition ,influencing factors ,mechanisms and various therapeutic methods .
出处 《心血管康复医学杂志》 CAS 2014年第5期577-580,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 江苏省自然科学基金资助项目(BK2012589)~~
关键词 冠状动脉再狭窄 支架 血栓形成 Coronary restenosis Stents Thrombosis
  • 相关文献

参考文献28

  • 1Camenzind E. Treatment of in-stent restenosis-back to the fu- ture? [J]. NEnglJ Med, 2006, 335 (20): 2149-2151.
  • 2Cosgrave J, Agostoni P, Ge L, et al. Clinical outcome following aleatory implantation of paclitaxel eluting or sirolimus eluting stents fn complex coronary lesions [J]. Am J Cardiol, 2005, 96 (12): 1663-1668.
  • 3Dangas GD, Claessen BE, Caixeta A, et al. In stent restenosis in the drug-eluting stent era [J]. J Am Coll Cardiol, 2010, 56 (23): 1897-1907.
  • 4Lemos PA, van Mieghem CA, Arampatzis CA, et al. Post siroli- mus-eluting stent restenosis treated with repeat percutaneous in- tervention: late angiographic and clinical outcomes [J]. Circula- tion, 2004, 109 (21): 2500-2502.
  • 5Cosgrave J, Melzi G, Corbett S, et al. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent [J]. Am Heart J, 2007, 153 (3): 354-359.
  • 6Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer- based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial [J]. JAMA, 2005, 294 (10): 1215-1223.
  • 7Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents [J]. NEnglJ Med, 2006, 354 (5): 483-495.
  • 8Dangas GD, Caixeta A, Mehran R, et al. Frequency and predic- tors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction [J]. Circulation, 2011, 123 (16) : 1745-1756.
  • 9Tsigkas GG, Karantalis V, Hahalis G, et al. Stent restenosis, pathophysiology and treatment options: a 2010 update [J]. Hel- lenicI Cardiol, 2011, 52 (2): 149-157.
  • 10Bhatia V, Kaul U. Management of in-stent restenosis after DES use [J]. Cardiac Interventions Today, 2011:50-55.

二级参考文献63

  • 1任节,段宝祥,毛建华.脑钠肽与心力衰竭[J].心血管康复医学杂志,2005,14(1):78-80. 被引量:19
  • 2潘长江,唐家驹,王进,黄楠.血管支架内再狭窄的机理研究进展[J].中国介入影像与治疗学,2005,2(4):314-317. 被引量:17
  • 3杨巍,葛均波,刘红玲.三氧化二砷洗脱支架防治兔血管损伤后再狭窄的实验研究[J].哈尔滨医科大学学报,2007,41(2). 被引量:2
  • 4Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51 (3): 606.
  • 5Mukoyama M, Nakao K, Saito Y, et al. Human brain natriuretic peptide, a novel cardiac hormone [J]. Lancet, 1990, 335 (8692):801-802.
  • 6Hama N, Itoh H, Shirakami G, et al. Rapid ventrieular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction [J]. Circulation, 1995, 92 (6) : 1558-1564.
  • 7de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease [J]. Lancet, 2003, 362 (9380): 316-322.
  • 8Kragelund C, GrOnning B, Omland T, et al. Is N-terminal pro B-type natriuretie peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease [J]? Am Heart J, 2006, 151 (3) : 712e1-712e7.
  • 9Abdullah SM, Khera A, Das SR, et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas heart study) [J]. Am J Cardiol, 2005, 96 (9): 1284-1289.
  • 10McClure SJ, Gall S, Schechter CB, et al. Percutaneous coronary revascularization reduces plasma N- terminal pro- B- type natriuretic peptide concentration in stable coronary artery disease [J]. J Am Coll Cardiol, 2007, 49 (25) : 2394-2397.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部